What Should We Quickly Know About Hemopoietic Malignancies?

Initial consultation for hemopoietic malignancies requires basic but important understanding of disease initiating mechanisms. In this chapter, we will discuss relevant germline predisposition advances for acute leukemia to assist in identification of susceptible family members and if required for appropriate selection of curative allogenic marrow donors. Additionally, we present current world health organization recommendations for classification of these malignancies and add brief review for initial evaluation of chronic myelogenous leukemia.